Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 106
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can cattle ventilate effectively while tilted in a chute and receiving veterinary care?

    Cattle are commonly presented to veterinarians for routine and emergent medical procedures. Lower limbs...

    Identifying genes to stop sarcomas in kids and dogs

    Sarcomas are life-threatening, often untreatable cancers that disproportionately affect dogs and children...

    Community-based Leishmaniasis research in Sri Lanka

    Leishmaniasisis a neglected tropical parasitic diseases in the world and is spread by the bite of sand flies...

    Backer Badge Funded